Skip to main content
Simrit Parmar, MD, Oncology, Houston, TX

SimritParmarMD

Oncology Houston, TX

Hematologic Oncology

Mdacc

Dr. Parmar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Parmar's full profile

Already have an account?

  • Office

    1515 Holcombe Blvd
    Houston, TX 77030
    Phone+1 713-792-6161

Education & Training

  • McGaw Medical Center of Northwestern University
    McGaw Medical Center of Northwestern UniversityFellowship, Hematology and Medical Oncology, 2001 - 2004
  • Michael Reese Hospital and Medical Center
    Michael Reese Hospital and Medical CenterResidency, Internal Medicine, 1998 - 2001
  • Dayanand Medical College
    Dayanand Medical College Class of 1998

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2021 - Present
  • CA State Medical License
    CA State Medical License 2007 - 2026
  • NY State Medical License
    NY State Medical License 2024 - 2026
  • AZ State Medical License
    AZ State Medical License 2022 - 2025
  • MS State Medical License
    MS State Medical License 2022 - 2025
  • TN State Medical License
    TN State Medical License 2022 - 2025
  • WA State Medical License
    WA State Medical License 2022 - 2025
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Assessment of Radiation Doses Delivered to Organs at Risk Among Patients with Early-Stage Favorable Hodgkin Lymphoma Treated with Contemporary Radiation Therapy  
    Chelsea C Pinnix, Jillian R Gunther, Sarah A Milgrom, Jason Westin, Simrit Parmar, Loretta Nastoupil, Sattva Neelapu, Bouthaina S Dabaja, JAMA Network Open
  • Primary Plasma Cell Leukemia: Autologous Stem Cell Transplant in an Era of Novel Induction Drugs  
    Krina Patel, Rohtesh Mehta, Donna M Weber, Sheeba K Thomas, Nina Shah, Hans C Lee, Elisabet E Manasanch, Muzaffar H Qazilbash, Qaiser Bashir, Simrit Parmar, Robert Z O..., Nature
  • Pilot Study Using Post-Transplant Cyclophosphamide (PTCy), Tacrolimus and Mycophenolate GVHD Prophylaxis for Older Patients Receiving 10/10 HLA-Matched Unrelated Donor...  
    Uday R Popat, Amin Alousi, Issa F Khouri, Muzaffar Qazilbash, Richard E Champlin, Partow Kebriaei, Simrit Parmar, Chitra Hosing, Nature
  • Join now to see all

Abstracts/Posters

  • Comparative Review of 30 Day Non-Relapse Mortality (NRM) in B-Cell Lymphomas Associated with Anti-CD19 Chimeric Antigen Receptor T-Cells (CAR-T) from FDA Database, Cli...
    Simrit Parmar, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019

Press Mentions

  • Acute Myeloid Leukemia Survivor Finds Hope with Clinical Trials
    Acute Myeloid Leukemia Survivor Finds Hope with Clinical TrialsDecember 4th, 2018

Professional Memberships